NDC 71335-0080

Clopidogrel

Clopidogrel Bisulfate

Clopidogrel is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Clopidogrel Bisulfate.

Product ID71335-0080_33aeac87-ad9d-4adf-9cb0-c6883508c332
NDC71335-0080
Product TypeHuman Prescription Drug
Proprietary NameClopidogrel
Generic NameClopidogrel Bisulfate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2012-05-17
Marketing CategoryANDA / ANDA
Application NumberANDA090540
Labeler NameBryant Ranch Prepack
Substance NameCLOPIDOGREL BISULFATE
Active Ingredient Strength75 mg/1
Pharm ClassesDecreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-0080-1

90 TABLET, FILM COATED in 1 BOTTLE (71335-0080-1)
Marketing Start Date2012-05-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-0080-1 [71335008001]

Clopidogrel TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090540
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-31

NDC 71335-0080-2 [71335008002]

Clopidogrel TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090540
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-31

NDC 71335-0080-4 [71335008004]

Clopidogrel TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090540
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-31

NDC 71335-0080-3 [71335008003]

Clopidogrel TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA090540
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-05-31

Drug Details

Active Ingredients

IngredientStrength
CLOPIDOGREL BISULFATE75 mg/1

OpenFDA Data

SPL SET ID:e8f98886-4771-4be3-8b57-edfbbc1b4661
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309362
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • P2Y12 Platelet Inhibitor [EPC]
    • P2Y12 Receptor Antagonists [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]